glp 1 lilly direct Some US employers to drop coverage of GLP-1 obesity drugs in 2027 as use increases Big update in the GLP-1

a - f , Treatment of C57BL/6 J DIO mice with once-daily subcutaneous (s.c.) injections of 900 nmol kg 1 MK-801 (n = 8 mice and n = 4 cages), 1800 nmol kg 1 MK-801 (n = 6 mice and n = 3 cages) or vehicle (isotonic saline, n = 7 mice and n = 3 cages) over 7 days

2016 Mar;29(1):23-8

Long-acting human GLP-1 drugs will be the main force in the diabetes market in the future

[12] Often, treatment may be needed for life

R.HartfordC.SrinivasanA.LaverJ.et al (2013)

Studies show it promotes angiogenesis (new blood vessel growth), stimulates tissue regeneration in muscle, tendon, ligament, and bone, reduces inflammation, and supports gut health increasing delivery of growth factors to injury sites and reducing inflammatory cytokines